Study of Efficacy of Different Treatment Regimens of Olokizumab
Clinical trial NCT05187793 · UNKNOWN
Trial details
- NCT number
- NCT05187793
- Sponsor
- R-Pharm
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2022-10-31
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.